Collegium Pharmaceutical (COLL) Accounts Payables (2014 - 2026)

Collegium Pharmaceutical's Accounts Payables history runs 13 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 61.75% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (down 61.75% YoY), while the FY2025 annual figure was $10.7 million, up 170.95% from the prior year.
• Accounts Payables was $6.8 million for Q1 2026 at Collegium Pharmaceutical, down from $10.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $17.9 million in Q1 2025 to a low of $2.4 million in Q2 2024.
• Historically, Accounts Payables has averaged $6.4 million across 5 years, with a median of $6.0 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables tumbled 63.48% in 2023, then surged 351.49% in 2025.
• A 5-year view of Accounts Payables shows it stood at $3.5 million in 2022, then surged by 148.77% to $8.7 million in 2023, then plunged by 54.74% to $3.9 million in 2024, then surged by 170.95% to $10.7 million in 2025, then tumbled by 35.94% to $6.8 million in 2026.
• The last three Accounts Payables figures came in at $6.8 million (Q1 2026), $10.7 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.